Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?

J Pernow, C Jung - Cardiovascular research, 2013 - academic.oup.com
Functional integrity of the vascular endothelium is of fundamental importance for normal
vascular function. A key factor regulating endothelial function is the bioavailability of nitric …

[HTML][HTML] Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases

Z Li, L Wang, Y Ren, Y Huang, W Liu, Z Lv, L Qian… - Cell Death …, 2022 - nature.com
Arginase, a binuclear manganese metalloenzyme in the urea, catalyzes the hydrolysis of L-
arginine to urea and L-ornithine. Both isoforms, arginase 1 and arginase 2 perform …

[HTML][HTML] Immune function of endothelial cells: evolutionary aspects, molecular biology and role in atherogenesis

S Kotlyarov - International Journal of Molecular Sciences, 2022 - mdpi.com
Atherosclerosis is one of the key problems of modern medicine, which is due to the high
prevalence of atherosclerotic cardiovascular diseases and their significant share in the …

Nitric oxide: a guardian for vascular grafts?

A de Mel, F Murad, AM Seifalian - Chemical reviews, 2011 - ACS Publications
Cardiovascular disease is a major cause of mortality and morbidity. Current research
investigating the roles of nitric oxide (NO) with relevance to the cardiovascular system is an …

[HTML][HTML] Role of arginase in vessel wall remodeling

W Durante - Frontiers in immunology, 2013 - frontiersin.org
Arginase metabolizes the semi-essential amino acid l-arginine to l-ornithine and urea. There
are two distinct isoforms of arginase, arginase I and II, which are encoded by separate …

Biomechanical factors and macrophages in plaque stability

A Seneviratne, M Hulsmans, P Holvoet… - Cardiovascular …, 2013 - academic.oup.com
Thin-cap fibroatheromas (TCFAs) or vulnerable atherosclerotic plaques are considered a
high-risk phenotype for acute cardiovascular events. TCFAs are identified by a thin rupture …

[HTML][HTML] There is no direct competition between arginase and nitric oxide synthase for the common substrate l-arginine

TY Momma, JI Ottaviani - Nitric Oxide, 2022 - Elsevier
Aims Extrahepatic arginases are postulated to be involved in cardiovascular-related
pathologies by competing with nitric oxide synthase (NOS) for the common substrate l …

Numerical simulation of normal nasal cavity airflow in Chinese adult: a computational flow dynamics model

J Tan, D Han, J Wang, T Liu, T Wang, H Zang… - European archives of …, 2012 - Springer
Our purpose is to simulate the airflow inside the healthy Chinese nose with normal nasal
structure and function by computational fluid dynamics (CFD) method and to analyze the …

Arginase–endothelial nitric oxide synthase imbalance contributes to endothelial dysfunction during chronic intermittent hypoxia

BJ Krause, R Del Rio, EA Moya… - Journal of …, 2015 - journals.lww.com
Objective: Chronic intermittent hypoxia (CIH), the main feature of obstructive sleep apnoea,
is associated with impaired vascular function despite unaltered response to nitric oxide …

Arginase as a critical prooxidant mediator in the binomial endothelial dysfunction‐atherosclerosis

LA Rabelo, FO Ferreira, V Nunes-Souza… - Oxidative Medicine …, 2015 - Wiley Online Library
Arginase is a metalloenzyme which hydrolyzes L‐arginine to L‐ornithine and urea. Since its
discovery, in the early 1900s, this enzyme has gained increasing attention, as literature …